US$ 22.16
semaglutide type 1 diabetes trial Efficacy and safety of once-weekly monotherapy versus placebo in patients with 2 (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a Clinical trials show semaglutide may
Description
It's GLP-1 shot day

It is administered once weekly by subcutaneous injection into the abdomen, thigh or upper arm

Yes, Wegovy can be used in people with type 2 diabetes, and it is one of the qualifying weight-related comorbidities that may make you eligible for treatment with a BMI of 27 or above

Semaglutide Medics provides safe, convenient, and doctor-guided weight loss treatment with prescription Semaglutide

For some, diet and exercise alone may not be enough
